Salvatierra O, Feduska N J, Cochrum K C, Najarian J S, Kountz S L, Belzer F O
Ann Surg. 1977 Oct;186(4):424-35. doi: 10.1097/00000658-197710000-00004.
A large, comprehensive renal transplant program has a major impact not only on patient care, but also on the medical center itself and the larger community. The program at this center has advanced from 15 transplants in 1964 to 141 transplants in 1976. Fifty-nine per cent of patients transplanted have functioning kidneys at this time, including 76 children. Rehabilitation was equal to prerenal disease level in 91% of 169 recipients who lived five years with a functioning graft. Basic research in such diverse areas as renal preservation and immunology, as well as clinical research in optimum immunosuppressive therapy, resulted in significant contributions. Refinement of the mixed lymphocyte culture improved living-related graft survival at two years: 100% for HLA-identical and 91% for non-HLA-identical grafts, compared to 66% reported by the Transplant Registry for the combined group. Modification of immunosuppression improved patient survival at two years: 100% and 86% for recipients of living-related and cadaver grafts, respectively, compared to 83% and 65% reported by the Transplant Registry. The complexity of care of the patient with end-stage renal failure has required active interaction between transplant surgeons and almost every major specialty. The vast clinical material has been a great asset for training transplant surgeons, nephrologists, fellows and residents of multiple specialties, and medical students. The medical center's relationship with communities within a 250 mile radius has been strengthened, as reflected in patient referrals and the development of a multi-community-supported organ procurement system, which has allowed us to perform over 100 cadaver transplants per year for the past three years. Thus the performance of 1,000 renal transplants at this center has resulted not only in rehabilitation of many renal failure patients, but also in expanded and improved research and teaching capabilities, bringing support from multiple medical disciplines and the general community.
一个大型的综合性肾移植项目不仅对患者护理有重大影响,对医疗中心本身以及更广泛的社区也有重大影响。该中心的项目已从1964年的15例移植发展到1976年的141例移植。目前,接受移植的患者中有59%的人肾脏功能正常,其中包括76名儿童。在169名接受有功能移植物且存活五年的受者中,91%的人的康复情况与肾前疾病水平相当。在肾脏保存和免疫学等不同领域的基础研究,以及最佳免疫抑制治疗的临床研究都做出了重大贡献。混合淋巴细胞培养的改进提高了亲属活体移植两年的存活率:HLA相同的移植为100%,非HLA相同的移植为91%,相比之下,移植登记处报告的联合组为66%。免疫抑制的调整提高了患者两年的存活率:亲属活体移植和尸体移植受者分别为100%和86%,相比之下,移植登记处报告的分别为83%和65%。终末期肾衰竭患者护理的复杂性要求移植外科医生与几乎每个主要专科积极互动。大量的临床资料对培训移植外科医生、肾病学家、多个专科的研究员和住院医师以及医学生来说是一笔巨大的财富。该医疗中心与半径250英里范围内社区的关系得到了加强,这体现在患者转诊以及多社区支持的器官获取系统的发展上,这使得我们在过去三年每年能够进行100多例尸体移植。因此,该中心进行的1000例肾移植不仅使许多肾衰竭患者得到了康复,还扩大和提高了研究与教学能力,获得了多个医学学科和广大社区的支持。